{"filings":[{"id":99205,"accession_number":"0001171843-26-002896","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q1 revenue up 14% to $166.3M; EPS $0.59; declares $0.31 dividend, adds $50M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue before reimbursements $151.8M (+10% YoY); net income $29.6M ($0.59 diluted EPS) vs $26.7M ($0.52).","EBITDA $43.1M (28.4% of net rev) vs $37.5M (27.3%) in prior year; 76% utilization.","Engineering & scientific segment +12% YoY driven by AI consumer electronics studies and utility risk mgmt; env/health +2%.","Q2 guidance: revenue growth high-single digits; EBITDA margin 27.0%-27.8%; FY2026 outlook maintained.","Dividend $0.31/share payable June 18; additional $50M buyback authorization, total ~$67.7M available."],"consensus_eps_estimate":null,"consensus_eps_actual":0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":166303000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99204,"accession_number":"0001171843-26-002263","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2026-04-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Exponent appoints John Pye as President, Eric Anderson as CFO; Paul Johnston retiring","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Pye appointed President effective May 1, 2026; base salary $650,000; receives 21,000 stock options vesting over 4 years.","Eric Anderson appointed CFO effective May 1, 2026; base salary $525,000; receives 12,600 stock options vesting over 4 years.","Rich Schlenker steps down as CFO but remains EVP; nominated to Board of Directors.","Paul Johnston to retire from Board at June 4, 2026 Annual Meeting; Karen Richardson becomes Chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115081,"accession_number":"0001171843-26-000654","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q4 revenue $147.4M (+7.8%), EPS $0.49; FY revenue $582M; dividend raised to $0.31","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenues $147.4M, up 7.8% YoY; net income $24.8M, diluted EPS $0.49 vs $0.46.","Fiscal 2025 total revenues $582.0M, up 4.2%; net income $106.0M, diluted EPS $2.07.","Engineering & scientific segment rev before reimbursements up 7% in Q4; environmental & health down 5%.","Quarterly dividend increased to $0.31/share, payable March 20, 2026 to holders of record March 6.","FY2026 guidance: rev before reimbursements growth high-single digits; EBITDA margin 27.6%-28.1%."],"consensus_eps_estimate":null,"consensus_eps_actual":2.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":582014000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131470,"accession_number":"0001171843-25-006835","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q3 net revenue up 10% YoY; raises FY2025 margin guidance; adds $100M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $147.1M; revenues before reimbursements up 10% to $137.1M; net income $28.0M ($0.55 EPS) vs $26.0M ($0.50 EPS) a year ago.","Engineering segment (84% of rev) and environmental/health segment each grew 10% and 9% respectively in Q3.","Full-year FY2025 guidance: revenues before reimbursements low single-digit growth; EBITDA margin raised to 27.4%-27.65%.","Board declared $0.30/share dividend payable Dec 19, 2025 (record Dec 5); also authorized additional $100M share repurchase.","YTD 2025: $46.7M dividends paid, $72.7M stock repurchased; cash and equivalents at $207.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":434589000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148060,"accession_number":"0001171843-25-004918","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q2 EPS $0.52 vs $0.57 YoY; revenues flat, guides Q3 mid-single digit growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS $0.52 (down from $0.57); net income $26.6M vs $29.2M in Q2 2024.","Revenue before reimbursements flat at $132.9M; total revenue $142.0M (+1% YoY).","EBITDA margin fell to 27.8% from 30.2%; environmental/health segment down 4%.","Q3 guidance: rev before reimb up mid-single digits; EBITDA margin 26.75%-27.75%.","Declares $0.30 quarterly dividend payable Sept 19, 2025; record Sept 5."],"consensus_eps_estimate":null,"consensus_eps_actual":1.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":287469000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166804,"accession_number":"0001171843-25-003818","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Exponent holds annual meeting; elects all six director nominees","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected: Brown, Corrigan, Johnston, Lindstrom, Richardson, Zumwalt.","KPMG ratified as independent auditor for fiscal 2025 with 46.7M votes for (97% of votes cast).","Advisory vote on executive compensation approved with 41.97M for vs 1.85M against.","No other material changes; shares outstanding as of record date: 50,757,382."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166803,"accession_number":"0001171843-25-002692","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q1 revenue flat at $145.5M; EPS down to $0.52; Q2 revenue guided down low-single digits","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues flat at $145.5M; revenues before reimbursements flat at $137.4M YoY.","Net income $26.7M ($0.52 diluted EPS) vs $30.1M ($0.59) in Q1 2024; negative tax impact of $0.5M.","EBITDA $37.5M (27.3% of net revenues) vs $40.1M (29.2%) in Q1 2024.","Guides Q2 revenues before reimbursements down low-single digits; full year low-single digit growth maintained.","Quarterly dividend of $0.30 per share declared, payable June 20, 2025 to holders of record June 6, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":145507000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184207,"accession_number":"0001171843-25-000676","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q4 rev up 11% to $136.8M; EPS $0.46; div raised to $0.30","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net income $23.6M ($0.46 diluted EPS) vs $20.9M ($0.41) a year ago; rev before reimb $123.8M (+8.7%).","FY2024 net income $109.0M ($2.11 diluted EPS) vs $100.3M ($1.94); rev before reimb $518.5M (+4.3%).","EBITDA margin improved to 28.4% for FY2024 (27.7% prior); Q4 EBITDA margin 25.2% vs 26.8%.","Guides Q1 2025 rev before reimb down low-single-digits; FY2025 rev growth low-single-digits, EBITDA margin 26.25-27.0%.","Quarterly dividend raised 7.1% to $0.30 from $0.28, payable March 21; 12th consecutive annual increase."],"consensus_eps_estimate":null,"consensus_eps_actual":2.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":558514000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200807,"accession_number":"0000950170-24-119889","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Exponent's Group VP Eric Guyer resigns effective Nov 8, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric Guyer, Ph.D., Group Vice President, resigned October 28, effective November 8, 2024.","No reason for resignation provided; no successor named in the filing.","Exponent, Inc. (EXPO) trades on Nasdaq Global Select Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200806,"accession_number":"0001171843-24-005815","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-10-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q3 net income up 6% to $0.50 EPS; revenue flat; raises FY EBITDA margin guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenues before reimbursements $125.1M (flat YoY); net income $26.0M (+6%, $0.50 diluted EPS vs $0.48).","EBITDA margin 28.6% (+100bps); utilization 75% in first nine months.","Engineering segment flat; environmental/health down 6% on chemical/life sciences headwinds.","FY2024 rev growth guided low-to-mid single digits; EBITDA margin raised to 27.9%-28.1%.","Dividend $0.28/share, payable Dec 20, record Dec 6 (unchanged from prior quarter)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":421748000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216811,"accession_number":"0001171843-24-004151","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-07-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q2 net income up 14% to $0.57 EPS; raises full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net income $29.2M ($0.57 EPS) up 14% YoY; revenue flat at $140.5M.","EBITDA margin expanded to 30.2% of revs before reimbursements vs 28.4% YoY.","Raised FY 2024 guidance: revs before reimbursements low-mid single digit growth; EBITDA margin 27.5%-28.0%.","Quarterly dividend declared at $0.28/share, payable Sep 20, record Sep 6.","Engineering & other scientific segment revs up 4% in Q2; environmental & health down 4%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":285469000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236536,"accession_number":"0000950170-24-076817","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-06-24T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Exponent extends Arizona lease to 2043; annual rent rises to $6.2M from $1M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Lease extension for 15 years starting Jan 17, 2028 through Jan 16, 2043.","Current annual rent of $1,009,000 holds until Jan 16, 2028; then jumps to $6,183,325 per year.","Rent adjusted every 5 years based on CPI, with first adjustment in 2033.","Lessee retains right to remove vertical improvements; no additional rent for improvements during extension."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236535,"accession_number":"0000950170-24-071983","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-06-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Exponent shareholders re-elect all six directors; approve equity plan amendment to increase shares to 13.34M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six director nominees elected; Karen Richardson appointed Lead Independent Director and Paul Johnston Chairman.","Shareholders ratified KPMG as auditor for FY2024 (47,890,461 for, 524,035 against) and approved advisory say-on-pay (41,591,520 for).","Amendment to 2008 Equity Incentive Plan approved, increasing authorized shares to 13,336,300 (43,635,280 for).","Committee chairs set: Brown (audit), Lindstrom (nominating/corp gov), Zumwalt (HR)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.15,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236534,"accession_number":"0001171843-24-002240","cik":851520,"company_name":"EXPONENT INC","ticker":"EXPO","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Exponent Q1 revs before reimbursements up 6.6% to $137.2M, EPS $0.59, raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues $144.9M (+3.3% YoY); net income $30.1M ($0.59 diluted EPS) vs $29.1M ($0.56).","EBITDA margin improved to 29.2% ($40.1M) from 27.8% ($35.8M); utilization 75%.","Engineering segment (84% of rev) grew 8% in rev before reimbursements; environmental/health (16%) grew 1%.","Q2 2024 guidance: rev before reimbursements flat to low-single-digit growth; EBITDA margin 27.25%-28.25%.","FY2024 guidance raised: low-single-digit revenue growth, EBITDA margin 26.25%-27.0% (increased from prior range)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":144933000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":2769043702.860222,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}